# DESCRIPTION

## FEDERALLY SPONSORED RESEARCH

- acknowledge government support

## BACKGROUND OF INVENTION

- motivate Usher syndrome treatment

## SUMMARY

- introduce Usher 1F treatment limitations
- motivate gene addition therapy
- describe PCDH15 coding sequence limitations
- introduce first 5′ isolated nucleic acid
- introduce first 3′ isolated nucleic acid
- introduce second 5′ and 3′ isolated nucleic acids
- summarize vector composition
- describe rAAV vector components
- outline rAAV vector embodiments
- describe capsid protein variants
- outline PCDH15 expression systems
- describe host cells and pharmaceutical compositions
- outline methods for treating hearing and vision loss
- describe treatment of Usher Syndrome, Type 1F

## DETAILED DESCRIPTION

- introduce gene therapy for autosomal recessive disorders

### I. Dual-AAV Vector System Encoding Full-Length PCDH15

- introduce dual-AAV vector system for expressing full-length PCDH15
- define nucleic acid sequence
- describe PCDH15 gene and its isoforms
- provide exemplary amino acid sequences for full-length human PCDH15
- describe dual-AAV vector system forming full-length PCDH15 coding sequence by trans splicing
- describe dual-AAV vector system forming full-length PCDH15 coding sequence by homologous recombination and splicing
- define 5' isolated nucleic acid and 3' isolated nucleic acid
- describe split site of PCDH15 coding sequence between 5' isolated nucleic acid and 3' isolated nucleic acid
- define promoter and its types
- describe operable linkage of promoter and nucleic acid sequence
- introduce dual-AAV vector system
- describe inducible promoters
- list native promoters
- describe tissue-specific promoters
- describe 3' isolated nucleic acid encoding PCDH15
- describe splicing donor and acceptor
- describe recombinogenic sequence and detectable protein
- describe polyadenylation sequence
- define dual-AAV vector system
- describe protein tags
- outline vector construction
- explain sequence identity
- describe ITRs and their modifications
- detail transgene expression
- provide exemplary vector sequences
- describe rAAV vectors for delivering full-length PCDH15
- define dual-AAV vector system
- describe first 3' rAAV
- describe second 5' rAAV
- describe second 3' rAAV
- provide isolated AAVs
- describe methods for obtaining recombinant AAVs
- describe AAV capsid proteins
- describe PCDH15 expression systems
- describe delivery of rAAVs to mammal
- describe host cells containing rAAVs

### III. Pharmaceutical Composition for Delivering Transgenes to the Ear and Eye

- describe rAAV composition
- formulate pharmaceutical composition
- select pharmaceutically acceptable carrier
- add buffering agent
- include surface-active agent
- administer rAAV composition
- determine effective amount of rAAV
- formulate for delivery using liposomes or nanocapsules

### IV. Therapeutic Applications

- describe therapeutic methods for hearing loss and blindness
- motivate PCDH15 gene therapy for Usher Syndrome type 1F
- outline methods for delivering transgene to target cells
- discuss effective amounts and modes of administration

## EXAMPLES

### Example 1. Dual AAV Vectors for Delivering Full-Length PCDH15 in Hair Cells and Retina Cells

- motivate Usher syndrome type 1F treatment
- describe limitations of conventional AAV gene therapy
- introduce dual vector AAV delivery of full-length PCDH15
- describe trans-splicing and hybrid methods for recombination
- detail vector design and packaging
- report expression and localization of full-length PCDH15 in hair cells
- describe rescue of mechanotransduction and hearing in knockout mice
- discuss potential for treating Usher syndrome type 1F patients

### Example 2. Morphological Hair Bundle Rescue in Pcdh15 Conditional Knockout Mice

- report robust hair bundle morphology rescue in knockout mice

### Example 3. HA-Tagged PCDH15 Trafficking to the Stereocilia

- demonstrate proper trafficking of HA-tagged PCDH15 to stereocilia tips

### Example 4. Hearing Rescue Using Dual Vectors Encoding PCDH15 or HA-PCDH15

- report robust hearing rescue in knockout mice using dual vectors

### Other Embodiments

- discuss alternative features and modifications of the invention

## EQUIVALENTS

- define scope of inventive embodiments
- clarify definitions and terminology

